John Overdeck’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229M Buy
4,209,861
+2,003,649
+91% +$97.6M 0.17% 130
2026
Q1
$94.6M Buy
2,206,212
+1,932,421
+706% +$83.1M 0.08% 290
2025
Q4
$12M Buy
273,791
+234,482
+597% +$9.7M 0.02% 1007
2025
Q3
$1.62M Sell
39,309
-601,990
-94% -$24.2M ﹤0.01% 2265
2025
Q2
$28.3M Sell
641,299
-957,984
-60% -$38.3M 0.05% 438
2025
Q1
$59M Buy
1,599,283
+270,730
+20% +$9.65M 0.13% 190
2024
Q4
$44.2M Buy
1,328,553
+478,889
+56% +$15.5M 0.1% 255
2024
Q3
$22M Buy
849,664
+305,007
+56% +$7.58M 0.05% 449
2024
Q2
$12.2M Sell
544,657
-196,466
-27% -$4.36M 0.03% 630
2024
Q1
$17.6M Buy
741,123
+165,982
+29% +$3.69M 0.04% 476
2023
Q4
$13.8M Sell
575,141
-1,229,614
-68% -$26.7M 0.03% 550
2023
Q3
$39.4M Buy
1,804,755
+76,200
+4% +$1.59M 0.11% 238
2023
Q2
$33M Buy
1,728,555
+803,382
+87% +$15.5M 0.08% 291
2023
Q1
$18M Buy
925,173
+787,381
+571% +$13.7M 0.05% 401
2022
Q4
$2.21M Buy
+137,792
New +$2.25M 0.01% 1283
2022
Q3
Sell
-262,792
Closed -$5.47M 2566
2022
Q2
$5.47M Sell
262,792
-665,769
-72% -$13.7M 0.02% 731
2022
Q1
$21.1M Buy
928,561
+228,173
+33% +$4.46M 0.06% 375
2021
Q4
$12.8M Buy
700,388
+99,536
+17% +$1.9M 0.03% 667
2021
Q3
$12.7M Buy
+600,852
New +$11.2M 0.03% 657
2020
Q4
Sell
-9,662
Closed -$236K 3442
2020
Q3
$236K Sell
9,662
-1,056,080
-99% -$24.7M ﹤0.01% 2717
2020
Q2
$25.3M Buy
+1,065,742
New +$24.7M 0.13% 174
2019
Q4
Sell
-107,296
Closed -$1.9M 3732
2019
Q3
$1.9M Sell
107,296
-133,439
-55% -$2.7M 0.01% 1484
2019
Q2
$5.14M Buy
+240,735
New +$5.05M 0.02% 878
2018
Q4
Sell
-219,624
Closed -$3.89M 3135
2018
Q3
$3.89M Buy
219,624
+49,317
+29% +$962K 0.01% 1069
2018
Q2
$3.67M Buy
+170,307
New +$3.52M 0.01% 1202
2018
Q1
Sell
-620,979
Closed -$18.9M 3244
2017
Q4
$18.9M Buy
620,979
+155,804
+33% +$4.14M 0.06% 386
2017
Q3
$11.3M Sell
465,175
-1,592,950
-77% -$42.4M 0.04% 479
2017
Q2
$50.7M Sell
2,058,125
-1,802,406
-47% -$38.1M 0.18% 139
2017
Q1
$83.7M Sell
3,860,531
-697,207
-15% -$14.2M 0.28% 66
2016
Q4
$68M Buy
4,557,738
+2,044,889
+81% +$29.5M 0.26% 79
2016
Q3
$32.1M Buy
2,512,849
+907,406
+57% +$9.81M 0.12% 193
2016
Q2
$12.5M Buy
1,605,443
+101,009
+7% +$582K 0.05% 413
2016
Q1
$6.02M Buy
1,504,434
+806,741
+116% +$3.41M 0.03% 636
2015
Q4
$3.94M Buy
697,693
+299,201
+75% +$1.67M 0.02% 765
2015
Q3
$2.24M Buy
+398,492
New +$2.17M 0.01% 798
2015
Q1
Sell
-120,603
Closed -$174K 2685
2014
Q4
$174K Buy
+120,603
New +$188K ﹤0.01% 2076
2014
Q3
Sell
-60,469
Closed -$205K 1832
2014
Q2
$205K Sell
60,469
-18,569
-23% -$64.1K ﹤0.01% 1967
2014
Q1
$280K Buy
+79,038
New +$538K ﹤0.01% 1703

Other funds holding EXEL

John Overdeck's EXEL Position: Q2 2026 in Review

John Overdeck increased its Exelixis (EXEL) stake by 91% in Q2 2026, buying an estimated $97.6M and bringing the position to 4,209,861 shares worth $229M. The position accounts for 0.17% of the portfolio, ranked #130.

John Overdeck first reported a position in EXEL in Q1 2014 and has held it in 38 quarters since. 753 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • John Overdeck held 4,209,861 shares of Exelixis worth $229M as of Q2 2026.
  • John Overdeck bought 2,003,649 Exelixis shares in Q2 2026, an estimated $97.6M.
  • Exelixis made up 0.17% of John Overdeck's portfolio in Q2 2026, its #130 holding.
  • John Overdeck first reported a position in Exelixis in Q1 2014 and has held it in 38 quarters since.
  • 753 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.